262 related articles for article (PubMed ID: 29506222)
1. Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults.
Napoli N; Strollo R; Defeudis G; Leto G; Moretti C; Zampetti S; D'Onofrio L; Campagna G; Palermo A; Greto V; Manfrini S; Hawa MI; Leslie RD; Pozzilli P; Buzzetti R;
J Clin Endocrinol Metab; 2018 May; 103(5):1921-1928. PubMed ID: 29506222
[TBL] [Abstract][Full Text] [Related]
2. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
[TBL] [Abstract][Full Text] [Related]
4. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
[TBL] [Abstract][Full Text] [Related]
5. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA).
Hjort R; Alfredsson L; Andersson T; Carlsson PO; Grill V; Groop L; Martinell M; Rasouli B; Storm P; Tuomi T; Carlsson S
Diabetes Metab; 2017 Dec; 43(6):536-542. PubMed ID: 28669512
[TBL] [Abstract][Full Text] [Related]
6. Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial.
Strollo R; Soare A; Manon Khazrai Y; Di Mauro A; Palermo A; Del Toro R; Fallucca S; Giovanna Belluomo M; Dugo L; Pianesi M; Pozzilli P; Napoli N
Endocrine; 2017 Jun; 56(3):667-674. PubMed ID: 27888435
[TBL] [Abstract][Full Text] [Related]
7. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density spectrum in individuals with type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes.
Hu Y; Li X; Yan X; Huang G; Dai R; Zhou Z
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3390. PubMed ID: 32748546
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
10. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus.
Yousefzadeh G; Gozashti M; Najafipour H; Gholamhosseinian NA; Bahramnejad A; Shokouhi M
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S52-5. PubMed ID: 27094870
[TBL] [Abstract][Full Text] [Related]
11. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.
Gennari L; Merlotti D; Valenti R; Ceccarelli E; Ruvio M; Pietrini MG; Capodarca C; Franci MB; Campagna MS; Calabrò A; Cataldo D; Stolakis K; Dotta F; Nuti R
J Clin Endocrinol Metab; 2012 May; 97(5):1737-44. PubMed ID: 22399511
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic volume is reduced in patients with latent autoimmune diabetes in adults.
Lu J; Hou X; Pang C; Zhang L; Hu C; Zhao J; Bao Y; Jia W
Diabetes Metab Res Rev; 2016 Nov; 32(8):858-866. PubMed ID: 27037998
[TBL] [Abstract][Full Text] [Related]
13. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
[TBL] [Abstract][Full Text] [Related]
14. Identification of a distinct phenotype of elderly latent autoimmune diabetes in adults: LADA China Study 8.
Niu X; Luo S; Li X; Xie Z; Xiang Y; Huang G; Lin J; Yang L; Liu Z; Wang X; Leslie RD; Zhou Z
Diabetes Metab Res Rev; 2019 Jan; 35(1):e3068. PubMed ID: 30160000
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes.
Liang H; Cheng Y; Tang W; Cui Q; Yuan J; Huang G; Yang L; Zhou Z
Acta Diabetol; 2019 Nov; 56(11):1225-1230. PubMed ID: 31367990
[TBL] [Abstract][Full Text] [Related]
16. Lower mortality and cardiovascular event rates in patients with Latent Autoimmune Diabetes In Adults (LADA) as compared with type 2 diabetes and insulin deficient diabetes: A cohort study of 4368 patients.
Wod M; Thomsen RW; Pedersen L; Yderstraede KB; Beck-Nielsen H; Højlund K
Diabetes Res Clin Pract; 2018 May; 139():107-113. PubMed ID: 29518492
[TBL] [Abstract][Full Text] [Related]
17. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
Buzzetti R; Tuomi T; Mauricio D; Pietropaolo M; Zhou Z; Pozzilli P; Leslie RD
Diabetes; 2020 Oct; 69(10):2037-2047. PubMed ID: 32847960
[TBL] [Abstract][Full Text] [Related]
18. Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).
Maddaloni E; Coleman RL; Pozzilli P; Holman RR
Diabetes Obes Metab; 2019 Sep; 21(9):2115-2122. PubMed ID: 31099472
[TBL] [Abstract][Full Text] [Related]
19. Latent Autoimmune Diabetes in Adults in North Indian Region: Assessment of β-Cell Function, Metabolic and Immunological Features.
Kumar A; de Leiva A
Metab Syndr Relat Disord; 2017 Dec; 15(10):494-499. PubMed ID: 29040050
[TBL] [Abstract][Full Text] [Related]
20. Serum sclerostin levels in Paget's disease and prostate cancer with bone metastases with a wide range of bone turnover.
Yavropoulou MP; van Lierop AH; Hamdy NA; Rizzoli R; Papapoulos SE
Bone; 2012 Jul; 51(1):153-7. PubMed ID: 22579776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
